↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Tyck till om SwePub Sök här!

Träfflista för sökning "WFRF:(Olsson K) "

Search: WFRF:(Olsson K)

Result 1-10 of 1620

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	2017 swepub:Mat__t
2.	Corbalan, R, et al. (author) Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry 2019 In: JAMA cardiology. - : American Medical Association (AMA). - 2380-6591 .- 2380-6583. ; 4:6, s. 526-548 Journal article (peer-reviewed)
3.	Bonaca, MP, et al. (author) Long-term use of ticagrelor in patients with prior myocardial infarction 2015 In: The New England journal of medicine. - 1533-4406. ; 372:19, s. 1791-1800 Journal article (peer-reviewed)
4.	Jukema, JW, et al. (author) Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1167-1176 Journal article (peer-reviewed)
5.	Ray, KK, et al. (author) Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 2019 In: The lancet. Diabetes & endocrinology. - 2213-8595 .- 2213-8587. ; 7:8, s. 618-628 Journal article (peer-reviewed)
6.	Roe, MT, et al. (author) Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes 2019 In: Circulation. - : Ovid Technologies (Wolters Kluwer Health). - 1524-4539 .- 0009-7322. ; 140:19, s. 1578-1589 Journal article (peer-reviewed)
7.	Steg, PG, et al. (author) Effect of Alirocumab on Mortality After Acute Coronary Syndromes 2019 In: Circulation. - 1524-4539. ; 140:2, s. 103-112 Journal article (peer-reviewed)
8.	Szarek, M, et al. (author) Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial 2019 In: Circulation. Cardiovascular quality and outcomes. - : Ovid Technologies (Wolters Kluwer Health). - 1941-7705 .- 1941-7713. ; 12:11, s. e005858- Journal article (peer-reviewed)
9.	Szarek, M, et al. (author) Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 73:4, s. 387-396 Journal article (peer-reviewed)
10.	Schwartz, GG, et al. (author) Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome 2018 In: The New England journal of medicine. - : MASSACHUSETTS MEDICAL SOC. - 1533-4406 .- 0028-4793. ; 379:22, s. 2097-2107 Journal article (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-10 of 1620

Refine your search

Type of publication: journal article (1277); conference paper (258); reports (19); book chapter (19); research review (18); other publication (14); show more...; doctoral thesis (5); book (4); licentiate thesis (2); patent (2); editorial proceedings (1); show less...

Type of content: peer-reviewed (1313); other academic/artistic (296); pop. science, debate, etc. (10)

Author/Editor: Zhang, Z. (117); Meyer, J. (108); Schmitt, S. (108); Lebedev, A. (107); Rizvi, E. (106); South, D. (106); show more...; Diaconu, C. (106); Ferencei, J. (106); Greenshaw, T. (106); Levonian, S. (106); Andreev, V. (106); Belousov, A. (106); Boudry, V. (106); Brisson, V. (106); Cvach, J. (106); Dodonov, V. (106); Eckerlin, G. (106); Egli, S. (106); Favart, L. (106); Fedotov, A. (106); Gabathuler, E. (106); Ghazaryan, S. (106); Goerlich, L. (106); Gogitidze, N. (106); Grab, C. (106); Horisberger, R. (106); Kapichine, M. (106); Kiesling, C. (106); Lubimov, V. (106); Malinovski, E. (106); Meyer, H. (106); Niebuhr, C. (106); Nowak, G. (106); Pascaud, C. (106); Perez, E. (106); Pitzl, D. (106); Klein, M. (105); Mehta, A. (105); Bystritskaya, L. (105); Felst, R. (105); Fomenko, A. (105); Gayler, J. (105); Haidt, D. (105); Herrera, G. (105); Janssen, X. (105); Kleinwort, C. (105); List, B. (105); Morozov, A. (105); Ozerov, D. (105); Reimer, P. (105); show less...

University: Karolinska Institutet (715); Lund University (464); Uppsala University (348); University of Gothenburg (164); Umeå University (94); Royal Institute of Technology (93); show more...; Linköping University (88); Chalmers University of Technology (82); Stockholm University (49); Örebro University (40); Swedish University of Agricultural Sciences (24); Linnaeus University (21); RISE (21); Kristianstad University College (20); Mid Sweden University (20); Karlstad University (17); Jönköping University (8); Luleå University of Technology (6); Södertörn University (6); Mälardalen University (5); University of Gävle (4); Malmö University (4); University of Skövde (4); Swedish Museum of Natural History (4); Högskolan Dalarna (3); Halmstad University (2); Stockholm School of Economics (2); The Swedish School of Sport and Health Sciences (2); Marie Cederschiöld högskola (2); Swedish Environmental Protection Agency (1); University of Borås (1); Swedish National Defence College (1); Blekinge Institute of Technology (1); Sophiahemmet University College (1); show less...

Language: English (1577); Swedish (32); Undefined language (7); French (2); Russian (1); Norwegian (1)

Research subject (UKÄ/SCB): Medical and Health Sciences (532); Natural sciences (330); Engineering and Technology (109); Social Sciences (61); Agricultural Sciences (34); Humanities (6)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view